BSE Code Company Date Purpose
table-arrow 524703 Sandu Pharma. 11-Jul-2026 Sandu Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/07/2026 inter alia to consider and approve 1. To place on record the demise of Shri Umesh B. Sandu(DIN:01132141) Managing Director of the Company on 19th June 2026 and to record the Boards appreciation for his invaluable contribution to the Company. 2. To consider and approve the appointment of a Managing Director of the Company pursuant to the demise of the erstwhile Managing Director Late Shri Umesh B. Sandu subject to the approval of the shareholders of the Company and such other statutory and regulatory approvals as may be required. 3. To consider and approve the reconstitution of the Committees of the Board. 4. To consider and approve the appointment of an Additional Director in the capacity of an Independent Director (Non-Executive) on the Board of the Company subject to the approval of the shareholders of the Company and such other statutory and regulatory approvals if any as may be required.
table-arrow 524723 Bijoy Hans 11-Jul-2026 Bijoy Hans Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/07/2026 inter alia to consider and approve 1. To consider & approve Acquisition of Sushodha Institute of Gastroenterology Private Limited and approval of Material Related Party Transactions with Mr. Bidari Kotresh Anilkumar. 2. To consider and evaluate a proposal for issuance of equity shares on a preferential basis for consideration other than cash (share swap). 3. To constitute Right Issue Committee of a Company. 4. To consider proposal to issue securities to the existing shareholders of the Company on Rights Basis as may be permitted under applicable law subject to such regulatory/statutory approvals as may be required. 5. To consider the approval for the postal ballot process and related actions.
table-arrow 530655 Goodluck India 11-Jul-2026 Goodluck India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/07/2026 ,inter alia, to consider and approve a) Issue of Bonus Equity Shares of the Company, subject to such statutory, regulatory and shareholders'' approvals as may be required. b) In principle, the proposed Corporate Restructuring of the Company, including evaluation of various restructuring options, subject to applicable laws and such approvals as may be required.
table-arrow 530709 Gowra Leasing 11-Jul-2026 Quarterly Results
table-arrow 532406 Avantel 11-Jul-2026 Avantel Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/07/2026 inter alia to consider and approve Board Meeting Intimation for Approval of Q1 Results - FY 2026-27